Fox Hill Wealth Management bought a new stake in Danaher Corporation (NYSE:DHR – Free Report) during the second quarter, HoldingsChannel.com reports. The firm bought 11,682 shares of the conglomerate’s stock, valued at approximately $2,225,000.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Meeder Asset Management Inc. acquired a new stake in shares of Danaher in the 2nd quarter valued at approximately $44,000. MidFirst Bank acquired a new position in Danaher during the 2nd quarter worth approximately $46,000. Bell Investment Advisors Inc acquired a new position in Danaher during the 2nd quarter worth approximately $47,000. Fiduciary Financial Advisors bought a new position in Danaher in the 2nd quarter valued at approximately $53,000. Finally, Solstein Capital LLC acquired a new stake in Danaher in the second quarter valued at approximately $58,000. Institutional investors own 79.05% of the company’s stock.
Danaher Stock Up 0.3%
Shares of NYSE:DHR opened at $216.41 on Friday. The firm has a market cap of $152.13 billion, a P/E ratio of 38.44, a P/E/G ratio of 2.69 and a beta of 0.78. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The business has a fifty day simple moving average of $199.46 and a 200 day simple moving average of $192.52. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.
Analysts Set New Price Targets
A number of research firms have weighed in on DHR. Guggenheim decreased their target price on shares of Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Piper Sandler began coverage on Danaher in a research note on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target for the company. Evercore reissued an “outperform” rating and set a $230.00 price objective on shares of Danaher in a report on Monday, July 6th. Wolfe Research cut Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $240.00 target price on shares of Danaher in a research report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $228.91.
Get Our Latest Analysis on Danaher
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
